Top Generic Anti-Cancer Drugs And Their Oncology Indications

Top Generic Anti-Cancer Drugs And Their Oncology Indications
4 Jul 2022
7 mins
Table Of Content
Top Generic Anti-Cancer Drugs And Their Oncology Indications

    Have you ever heard of generic medicines and wondered what they are? Read to know what generic medicines are, top generic anti-cancer drugs, and their oncology indications. 


    What Are Generic Medicines, And Why Are They Less Expensive?


    Original manufacturer holds patent protection for 20 years for a brand-name medicine. During this period, only the company that holds a patent can produce and sell that medicinal product, and they can fix the price to recover the expenses spent on research, development, and marketing of the new drug. 


    Once the patent expires, other pharma companies can start producing and selling the generic version of the drug. The generic version of the drug has the same active ingredient and must meet the same safety and quality standards. Other companies can produce generic versions and they do not have to invest in research and development, hence generic drugs are lower in price. 

    Top Generic Cancer Medicines And Their Cancer Indications:




    The chemotherapy drug cisplatin is used in the treatment of various cancers such as bladder cancer, ovarian cancer, testicular cancer, breast cancer, cancer of the lip and oral cavity, cervix uteri cancer, lung cancer, esophagus cancer, stomach cancer, and blood cancer. It is given intravenously and may be given alone or in combination with other medications. This medication works by damaging the genetic material of the cancer cells and stops their growth. 




    Carboplatin is a chemotherapy drug that helps treat cancers of the breast, cervix, uteri, lungs, esophagus, ovaries, blood, lips, and oral cavity. This medication is generally given intravenously but can be given intraperitoneally also (into the peritoneal cavity of the abdomen). Carboplatin forms reactive complexes that modify the DNA (genetic material) structure, inhibit DNA synthesis, and arrest tumor cell development. 




    The oncology indications of docetaxel include use in the treatment of cancers of the lungs, esophagus, uterus, cervix, oral cavity, stomach, ovary, prostate, head, and neck. It is given intravenously and may be given in combination with anti-cancer drugs. Docetaxel inhibits the microtubule structures found in the cell. Microtubule structures help tumor cells to divide and multiply, and inhibition of these structures slows the growth of tumor cells.




    Paclitaxel is used for treating stomach cancer, ovarian cancer, esophagus cancer, lung cancer, cervix uteri cancer, breast cancer, oral cancer, bladder cancer, and Kaposi’s sarcoma. Like docetaxel, paclitaxel also slows the growth of cancer cells by inhibiting the microtubule structures found in the cell. It is given as an infusion or injection into the vein and may be prescribed with other cancer drugs. 




    Cyclophosphamide is used in the treatment of breast cancer, blood cancer, ovarian cancer, blood cancer, and eye cancer. This medication can be given through different routes depending upon the condition being treated and dosage. Usually, it is given intravenously or in tablet form. Cyclophosphamide damages the hereditary material (RNA & DNA) of the cancer cells and arrests their growth. 




    This anti-cancer medication is used for treating numerous cancers such as esophagus cancer, colorectal cancer, stomach cancer, oral cancer, breast cancer, and many common cancers. Depending on the condition and diagnosis, this medication may be given as an injection into the vein or as a topical ointment. After administration, 5-fluorouracil forms a complex that interferes with genetic material synthesis and function. This inhibits the multiplication of rapidly-growing cancer cells. 




    Irinotecan is indicated for use in the treatment of colorectal cancer, uterus cancer, cervix cancer, lung cancer, stomach cancer, and esophagus cancer. It is administered intravenously and may be given alone or in combination with other medicines. Irinotecan stops the growth and spread of cancer cells by inhibiting the topoisomerase enzyme. Topoisomerase enzymes control the manipulation of the DNA structure necessary for replication. 




    This cytotoxic drug treats cancers of the lung, breast, bladder, ovarian, and pancreas and may be given along with other cancer medicines. Gemcitabine inhibits the thymidylate synthetase enzyme, resulting in inhibition of genetic material synthesis in the cancer cells. This prevents the growth of cancer cells. It is given through a vein by infusion. 




    Capecitabine treats cancers of the colon, stomach, rectum, breast, ovary, and food pipe. It is a given as a pill and may be used either alone or in combination with other drugs. By inhibiting DNA synthesis, capecitabine prevents the growth of cancer cells. 




    Etoposide treats testicular cancer, lung cancer, blood cancer, and ovarian cancer. It inhibits the enzyme DNA topoisomerase II, thereby inhibiting DNA synthesis. This prevents the growth of cancer cells. Etoposide will be given in tablet form or as an infusion into the vein. 

    Learn, Explore, And Reduce The Burden


    Understanding and learning the disease as well as treatment options can help you cope better and find out the best possible options. For certain high-cost medicines, manufacturers offer patient assistance programs (PAP) that can reduce the financial burden. You can get maximum discounts for cancer medicines with PAP.

    Written by
    GuruvigneshwariContent Writer
    AboutM.Pharmacy (Pharmacognosy)
    Tags :Cancer medicationsoncology indications of generic drugsgeneric anti-cancer medicines